Skip to main content
. 2021 Jun 19;43(2):199–239. doi: 10.1210/endrev/bnab019
Practical tip/synthesis:
• Table 4 summarizes the most recently published international consensus on follow-up of asymptomatic SDHx mutation carriers.
• Table 5 summarizes suggestions on follow-up of patients with a history of a cluster 1-related tumor.